Microbot Medical Statistics
Total Valuation
MBOT has a market cap or net worth of $153.79 million. The enterprise value is $74.53 million.
Important Dates
The last earnings date was Wednesday, November 12, 2025, after market close.
| Earnings Date | Nov 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MBOT has 67.16 million shares outstanding. The number of shares has increased by 132.48% in one year.
| Current Share Class | 67.16M |
| Shares Outstanding | 67.16M |
| Shares Change (YoY) | +132.48% |
| Shares Change (QoQ) | +31.81% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 13.75% |
| Float | 67.16M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 38.66 |
| PB Ratio | 1.93 |
| P/TBV Ratio | 1.97 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 27.53, with a Debt / Equity ratio of 0.01.
| Current Ratio | 27.53 |
| Quick Ratio | 27.32 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -31.87% and return on invested capital (ROIC) is -21.13%.
| Return on Equity (ROE) | -31.87% |
| Return on Assets (ROA) | -20.17% |
| Return on Invested Capital (ROIC) | -21.13% |
| Return on Capital Employed (ROCE) | -17.81% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$653,500 |
| Employee Count | 20 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +131.34% in the last 52 weeks. The beta is 1.18, so MBOT's price volatility has been higher than the market average.
| Beta (5Y) | 1.18 |
| 52-Week Price Change | +131.34% |
| 50-Day Moving Average | 2.58 |
| 200-Day Moving Average | 2.50 |
| Relative Strength Index (RSI) | 53.46 |
| Average Volume (20 Days) | 2,463,920 |
Short Selling Information
The latest short interest is 4.35 million, so 6.48% of the outstanding shares have been sold short.
| Short Interest | 4.35M |
| Short Previous Month | 4.23M |
| Short % of Shares Out | 6.48% |
| Short % of Float | 6.48% |
| Short Ratio (days to cover) | 1.48 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -14.04M |
| Pretax Income | -13.07M |
| Net Income | -13.07M |
| EBITDA | -13.97M |
| EBIT | -14.04M |
| Earnings Per Share (EPS) | -$0.39 |
Full Income Statement Balance Sheet
The company has $80.16 million in cash and $899,000 in debt, giving a net cash position of $79.26 million or $1.18 per share.
| Cash & Cash Equivalents | 80.16M |
| Total Debt | 899,000 |
| Net Cash | 79.26M |
| Net Cash Per Share | $1.18 |
| Equity (Book Value) | 78.22M |
| Book Value Per Share | 1.19 |
| Working Capital | 77.85M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$10.98 million and capital expenditures -$42,000, giving a free cash flow of -$11.02 million.
| Operating Cash Flow | -10.98M |
| Capital Expenditures | -42,000 |
| Free Cash Flow | -11.02M |
| FCF Per Share | -$0.16 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MBOT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -132.48% |
| Shareholder Yield | -132.48% |
| Earnings Yield | -8.50% |
| FCF Yield | -7.17% |
Analyst Forecast
The average price target for MBOT is $12.00, which is 424.02% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $12.00 |
| Price Target Difference | 424.02% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 5, 2018. It was a reverse split with a ratio of 1:15.
| Last Split Date | Sep 5, 2018 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |